• Title of article

    Reply to Comment on: Lung Perfusion Imaging with Technetium-99m-macroaggregated Albumin should be Combined with Contrast-enhanced Echocardiography for the Diagnosis of Hepatopulmonary Syndrome

  • Author/Authors

    Assadi, Majid Bushehr University of Medical Sciences - Bushehr Medical University Hospital - The Persian Gulf Nuclear Medicine Research Center - Department of Molecular Imaging and Radionuclide Therapy (MIRT) - Bushehr, Iran

  • Pages
    2
  • From page
    67
  • To page
    68
  • Abstract
    We appreciate the authors for their interest and knowledgeable comments on our study (1). We completely agree with them on dividing the geometric mean of brain counts by 0.13 since the brain is presumed to receive 13% of the cardiac output (2). We have used this score for shunt calculation.The relationship between brain uptake and quantitation of the right-to-left (R -L) shunt percentage using technetium-99m (Tc-99m)-macroaggregated albumin (MAA) whole-body imaging has been rarely investigated. Ito et al. (3) studied 53 patients and found thatTc-99-MAA brain uptake could completely distinguish patients with or without an R-L shunt and that it could provide complementary information and appears promising in predicting clinical outcomes
  • Keywords
    contrast-enhanced echocardiography , lung perfusion scintigraphy , technetium-99m-macroaggregated albumin , right-to-left shunt , Hepatopulmonary syndrome
  • Journal title
    Molecular Imaging and Radionuclide Therapy
  • Serial Year
    2021
  • Record number

    2573659